Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: The Effect of GD-iExo-003 in Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of GD-iExo-003 for acute ischemic stroke is currently recruiting, sponsored by Xuanwu Hospital in Beijing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GD-iExo-003

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Acute Ischemic Stroke | Phase 1, Phase 2 | Status: RECRUITING